Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00170534
Other study ID # 02-106
Secondary ID
Status Terminated
Phase N/A
First received September 12, 2005
Last updated August 26, 2010
Start date October 2004
Est. completion date April 2007

Study information

Verified date April 2009
Source National Institute of Allergy and Infectious Diseases (NIAID)
Contact n/a
Is FDA regulated No
Health authority Unspecified
Study type Interventional

Clinical Trial Summary

The specific aim of this study is to complete an ongoing randomized controlled trial of the efficacy of behavioral intervention compared to STI treatment/HIV counseling alone in decreasing risk behavior and incident HIV/STI infections in Mumbai, India.


Description:

India has the second highest number of HIV infections of any country in the world, and the epidemic continues unabated. This trial is focused on high risk men attending public STI clinics. A proposed 2 and a half year study, this trial will utilize the continuation of a randomized controlled trial of a behavioral intervention compared to HIV C&T and STI treatment alone targeting HIV uninfected male STI patients. The specific aims are to complete the current behavioral intervention trial and to expand the current investigations to include: the evaluation of men who have sex with men as well as women and evaluate the use of alcohol to the entire sample of recruited men. STI patients will be recruited from three sites and if randomized will agree to a 12 month participation commitment. Strategies employed in both arms of the trial are simple and the fundamental components of an HIV prevention strategy. By demonstrating their effectiveness in India the hope is to encourage the public health leadership to adopt them and continue to change drug treatment availability.


Recruitment information / eligibility

Status Terminated
Enrollment 1892
Est. completion date April 2007
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 16 Years and older
Eligibility Inclusion Criteria:

1. Males, over 16 years of age

2. Hindu or Marathi speakers

3. Have no plan to move permanently out of Mumbia in the following 12 months

4. have a symptom of an STI or have had a sexual exposure in the past 6 months. A sexual exposure is defined as having sex with a commercial sex worker (FSW), having unprotected sex with anyone, male or female, or if the patient came to the clinic seeking an HIV test.

5. Patients will be required to provide an address that can be located by a tracer.

Exclusion Criteria:

1. HIV positive subjects.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Prevention


Intervention

Behavioral:
Behavior


Locations

Country Name City State
India Lokmanya Tilak Municipal General Hospital Mumbai

Sponsors (1)

Lead Sponsor Collaborator
National Institute of Allergy and Infectious Diseases (NIAID)

Country where clinical trial is conducted

India, 

See also
  Status Clinical Trial Phase
Terminated NCT03098394 - Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted Infections N/A
Completed NCT03186183 - GPS: Adaptation Trial of an HIV Prevention Counselling Program for HIV-positive and HIV-negative Gay and Bisexual Men N/A
Completed NCT05504954 - A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA N/A
Completed NCT01387646 - Behavioral Intervention for Minority Adolescent Women Phase 2
Recruiting NCT04585165 - User-friendly HIV Testing and Counseling Services
Completed NCT04021953 - The People Like Us Evaluation Study N/A
Completed NCT02993185 - Making Healthy Decisions: A Trial Evaluating the "Your Move" Teen Pregnancy-prevention Intervention N/A
Active, not recruiting NCT01088542 - The Community Youth Development Study: A Test of Communities That Care N/A
Completed NCT01379599 - Brief Intervention to Reduce STDs in ER Drug Users Phase 3
Recruiting NCT05244967 - Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility
Recruiting NCT05766904 - Efficacy Trial on Meningococcal B Vaccine for Preventing Gonorrhea Infections Phase 3
Completed NCT00170430 - Reducing Vaginal Infections in Women Phase 3
Completed NCT03431168 - A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV Phase 2
Recruiting NCT04446611 - Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes N/A
Completed NCT02868346 - Improving the Diagnosis of Sexually Transmitted Infections in Emergency Rooms N/A
Completed NCT02740998 - Long-Acting Progestin Contraception and the Vaginal Microbiome
Completed NCT04207151 - Expanding PrEP By Embedding Unannounced SNAPS Navigators in High STI Testing Clinical Sites N/A
Completed NCT02498067 - rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities N/A
Active, not recruiting NCT05541081 - Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe N/A
Active, not recruiting NCT05708014 - Personalized Prevention for Couples: A 16-month Digital RCT N/A